Botulinum toxin A and neuropathic pain: An update - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Toxicon Année : 2023

Botulinum toxin A and neuropathic pain: An update

Résumé

Botulinum toxin type A is a widely used neurotoxin for the treatment of muscle hyperactivity such as dystonia and spasticity. Several clinical trials have also reported an efficacy of subcutaneous or intradermal administrations of botulinum toxin A on various neuropathic pain conditions including idiopathic trigeminal neuralgia and found that specific sensory phenotypes were predictors of the response. This narrative review summarizes the potential mechanisms of action, efficacy and safety of botulinum toxin A in neuropathic pain as well as its place in the therapeutic algorithm of neuropathic pain.
Fichier non déposé

Dates et versions

hal-04190822 , version 1 (30-08-2023)

Identifiants

Citer

A. Spagna, Nadine Attal. Botulinum toxin A and neuropathic pain: An update. Toxicon, 2023, 232, ⟨10.1016/j.toxicon.2023.107208⟩. ⟨hal-04190822⟩
8 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More